We are live on ! Find out more
DHFB

Dixon Hubard Feinour & Brown Portfolio holdings

AUM $842M
1-Year Est. Return 2.74%
This Fund
S&P 500
This Quarter Est. Return
+10.09%
1 Year Est. Return
-2.74%
3 Year Est. Return
+59.78%
5 Year Est. Return
+118.87%
10 Year Est. Return
AUM
$390M
AUM Growth
+$4.4M
Cap. Flow
-$11.6M
Cap. Flow %
-2.97%
Top 10 Hldgs %
36.69%
Holding
189
New
3
Increased
22
Reduced
93
Closed
8

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$8.09M
2
QRVO icon
Qorvo
QRVO
+$3.18M
3
DXCM icon
DexCom
DXCM
+$296K
4
TEAM icon
Atlassian
TEAM
+$225K
5
QLYS icon
Qualys
QLYS
+$221K

Top Sells

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$9.79M
2
CNC icon
Centene
CNC
+$1.4M
3
AAPL icon
Apple
AAPL
+$1.26M
4
AMZN icon
Amazon
AMZN
+$757K
5
LULU icon
lululemon athletica
LULU
+$746K

Sector Composition

Rank Sector Weight
1 Healthcare 24.4%
2 Technology 24.34%
3 Consumer Discretionary 11.23%
4 Communication Services 8.9%
5 Consumer Staples 7.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSX icon
101
CSX Corp
CSX
$93.1B
$535K 0.14%
20,667
-7,992
-28% -$197K
SPY icon
102
State Street SPDR S&P 500 ETF Trust
SPY
$810B
$528K 0.14%
1,577
+8
+0.5% +$2.65K
NOC icon
103
Northrop Grumman
NOC
$81.2B
$525K 0.13%
1,664
-50
-3% -$16.3K
NVDA icon
104
NVIDIA
NVDA
$5.42T
$514K 0.13%
38,000
-16,600
-30% -$193K
AZN icon
105
AstraZeneca
AZN
$250B
$476K 0.12%
4,343
+1,338
+45% +$149K
TEAM icon
106
Atlassian
TEAM
$37.8B
$456K 0.12%
2,510
+1,260
+101% +$225K
MDT icon
107
Medtronic
MDT
$112B
$447K 0.11%
4,298
-40
-0.9% -$4.02K
VIG icon
108
Vanguard Dividend Appreciation ETF
VIG
$114B
$445K 0.11%
3,455
-690
-17% -$86.8K
ELV icon
109
Elevance Health
ELV
$85.5B
$436K 0.11%
1,625
UNP icon
110
Union Pacific
UNP
$174B
$431K 0.11%
2,188
SEDG icon
111
SolarEdge
SEDG
$1.95B
$429K 0.11%
1,800
-125
-6% -$24K
EFA icon
112
iShares MSCI EAFE ETF
EFA
$80.2B
$426K 0.11%
6,700
-525
-7% -$33.6K
GLD icon
113
SPDR Gold Trust
GLD
$142B
$418K 0.11%
2,360
AAP icon
114
Advance Auto Parts
AAP
$3.49B
$406K 0.1%
2,646
NCLH icon
115
Norwegian Cruise Line
NCLH
$8.84B
$388K 0.1%
22,700
DIA icon
116
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$48.5B
$386K 0.1%
1,390
V icon
117
Visa
V
$677B
$386K 0.1%
1,928
HALO icon
118
Halozyme
HALO
$12.2B
$367K 0.09%
13,968
LRCX icon
119
Lam Research
LRCX
$390B
$358K 0.09%
10,800
MO icon
120
Altria Group
MO
$114B
$354K 0.09%
9,163
-1,779
-16% -$74K
OTIS icon
121
Otis Worldwide
OTIS
$28.2B
$349K 0.09%
5,593
-294
-5% -$18K
PM icon
122
Philip Morris
PM
$295B
$344K 0.09%
4,583
-55
-1% -$4.24K
INFO
123
DELISTED
IHS Markit Ltd. Common Shares
INFO
$343K 0.09%
4,370
-225
-5% -$17.9K
CARR icon
124
Carrier Global
CARR
$52.8B
$342K 0.09%
11,190
-588
-5% -$16.6K
HON icon
125
Honeywell
HON
$78B
$339K 0.09%
2,182

Similar funds

Dixon Hubard Feinour & Brown's Q3 2020 Portfolio in Review

As of Q3 2020, Dixon Hubard Feinour & Brown held 189 positions worth $390M, up 1.1% from $385M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Dixon Hubard Feinour & Brown's Q3 2020 filing shows 3 new, 22 increased, 93 reduced and 8 closed positions. Its largest new stake was Qorvo: 25,635 shares worth $3.31M. The largest sale was Edwards Lifesciences, an estimated $9.79M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Dixon Hubard Feinour & Brown's largest Q3 2020 buy was Qorvo: 25,635 shares worth $3.31M.
  • Dixon Hubard Feinour & Brown added most to UnitedHealth in Q3 2020, an estimated $8.09M increase.
  • Dixon Hubard Feinour & Brown's biggest Q3 2020 reduction was Apple, cutting an estimated $1.26M.
  • Dixon Hubard Feinour & Brown fully exited Edwards Lifesciences in Q3 2020, selling an estimated $9.79M.
  • Dixon Hubard Feinour & Brown's ten largest holdings make up 37% of its $390M portfolio in Q3 2020.
  • Dixon Hubard Feinour & Brown opened 3 new positions and closed 8 in Q3 2020.
  • Dixon Hubard Feinour & Brown's portfolio value rose 1.1% quarter-over-quarter to $390M.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q3 2020, filed 12 Nov 2020.